Can I take polyethylene glycol 3350 (Miralax) together with magnesium citrate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Can You Take Miralax and Magnesium Citrate Together?

Yes, you can take Miralax (polyethylene glycol 3350) and magnesium citrate together, and this combination is actually used clinically for bowel preparation, particularly before colonoscopy procedures.

Evidence for Combined Use

The combination of these two osmotic laxatives has been studied specifically for bowel preparation. A randomized trial demonstrated that split-dose magnesium citrate (250 ml) followed by 2 liters of PEG on the day of colonoscopy was more efficient than conventional 4-liter PEG alone and was equally effective as split-dose PEG regimens 1. This study showed 75% satisfactory bowel preparation with the magnesium citrate-PEG combination, with patients reporting higher satisfaction and willingness to repeat the regimen compared to PEG alone.

Mechanism and Safety Considerations

Both agents work as osmotic laxatives but through slightly different mechanisms:

  • Miralax (PEG 3350): A long-chain polymer that acts as a hypo-osmotic laxative, drawing water into the colon 2
  • Magnesium citrate: A hyper-osmotic agent that also draws fluid into the intestinal lumen 3

Critical Safety Warning

Avoid magnesium citrate in patients with renal insufficiency due to risk of hypermagnesemia 2. This is the most important contraindication when considering this combination.

Clinical Context

While the combination is proven safe and effective for bowel preparation, the evidence base primarily addresses:

  1. Short-term use for colonoscopy preparation (single or split doses over 1-2 days) 1
  2. Sequential dosing rather than simultaneous administration

For chronic constipation management, guidelines recommend these agents as separate options rather than routinely combining them 2. PEG 3350 alone at 17g daily has demonstrated sustained efficacy and safety for up to 6 months in chronic idiopathic constipation 2, 4.

Practical Recommendations

  • For bowel preparation: The combination is well-established and preferred by patients 1
  • For chronic constipation: Start with PEG 3350 alone (17g daily) as first-line therapy 2
  • If inadequate response: Consider dose adjustment of PEG before adding magnesium citrate
  • Check renal function before using magnesium citrate, especially in elderly patients or those with known kidney disease

Expected Side Effects

Both agents can cause:

  • Diarrhea (expected therapeutic effect)
  • Abdominal cramping
  • Bloating and flatulence
  • Nausea 2, 1

These effects are generally mild to moderate and decrease after the first week of treatment with PEG 4.

References

Related Questions

Can polyethylene glycol 3350 (Miralax) be administered to a 3‑year‑old child?
Can I use MiraLAX (polyethylene glycol 3350) with milk‑of‑magnesium (magnesium hydroxide) as a bridge until MiraLAX works?
Can a nine-month-old infant be started on MiraLax (polyethylene glycol 3350) for hard stool?
Can a patient with a colostomy bag safely take MiraLAX (polyethylene glycol 3350) to treat a colonic stool burden identified on computed tomography?
For how many days can Surelax (polyethylene glycol 3350) be used safely?
Can a patient take tadalafil 5 mg daily and also take an additional dose on an as‑needed (prn) basis?
In a 33-year-old woman with a positive EndoSure test, what are the next steps in management?
What is the appropriate weight‑based dexamethasone dose (max 10 mg) for treating an acute allergic rash and itching, and how should it be administered?
Is it safe to take chlorthalidone and hydrochlorothiazide together?
How should I inform a patient that a hip mass could be malignant?
How should hemoglobin and hematocrit be monitored in a male patient receiving testosterone therapy for hypogonadism?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.